What type of study is this?

This is a Single-Cell RNA-Sequencing study (also classified as: Observational).

Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation

View Full Paper

Ask AI

Bookmark

Authors

Research reveals Tgfbr2 deletion mitigates liver fibrosis by modulating angiocrine signalling and macrophage activity.

Tgfbr2 deficiency reduces liver fibrosis by regulating macrophage recruitment and angiocrine signalling.
ScRNA-seq data indicates TGFBR2 levels are higher in LSECs from cirrhotic individuals compared to healthy ones.
LSEC-specific Tgfbr2 knockout showed decreased capillarisation and inflammatory responses during liver injury.
Findings suggest targeting TGFBR2 in LSECs may be an effective strategy for managing liver fibrotic diseases.

Huang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark